ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: William Longmire Replaces Fisher On Cancer Panel; Talbot Urges Organizations To Avoid Polarization

July 9, 1982

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

Osteoporosis Treatments Associated With Decreased Risk Of Breast Cancer

March 26, 2010

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction

August 21, 1981